<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04729270</url>
  </required_header>
  <id_info>
    <org_study_id>tDCS</org_study_id>
    <nct_id>NCT04729270</nct_id>
  </id_info>
  <brief_title>Treatment of Neck Pain With Transcranial Direct Current Stimulation</brief_title>
  <official_title>Treatment of Neck Pain With Transcranial Direct Current Stimulation: A Single Blind Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Cadiz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Cadiz</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aim to investigate the effects of Transcranial Direct Current Stimulation for&#xD;
      improving pressure pain thresholds (PPTs), range of motion,Neck Disability Index, the&#xD;
      multidimensional health related quality of life (SF-12) and the multidimensional health&#xD;
      related quality of life and pain in patients with mechanical neck pain (NP).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Fifty-four participants with NP will randomly allocated to either an Transcranial Direct&#xD;
      Current Stimulation (ten sessions) or transcutaneous electric nerve stimulation (TENS) (ten&#xD;
      sessions) during two weeks. . Visual Analogue Scale (VAS), Neck Disability Index ( NDI),&#xD;
      range of motion and (CROM), Questionnaire SF-12 and PPTs in sub-occipital and upper trapezius&#xD;
      muscles were measured at baseline, at the end of treatment and at 1 month follow-up. T-tests&#xD;
      and a repeated-measures multivariate analysis of variance (RM-MANOVA) were used for VAS, CROM&#xD;
      and PPTs, respectively.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 25, 2021</start_date>
  <completion_date type="Anticipated">May 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 28, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>RANDOMIZED CLINICAL TRIAL WITH BLIND EVALUATION BY THIRD PARTIES, LONGITUDINAL AND PROSPECTIVE.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
    <masking_description>Blind researcher</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>The intensity of cervical pain</measure>
    <time_frame>Baseline</time_frame>
    <description>A 10-point Numerical Pain Rating Scale (NPRS; 0: no pain, 10: maximum pain) will be used to assess the patients' current level of cervical pain, and the worst and lowest level of pain experienced in the preceding week in the cervical area.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The intensity of cervical pain</measure>
    <time_frame>Four weeks</time_frame>
    <description>A 10-point Numerical Pain Rating Scale (NPRS; 0: no pain, 10: maximum pain) will be used to assess the patients' current level of cervical pain, and the worst and lowest level of pain experienced in the preceding week in the cervical area.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The intensity of cervical pain</measure>
    <time_frame>Twelve weeks</time_frame>
    <description>A 10-point Numerical Pain Rating Scale (NPRS; 0: no pain, 10: maximum pain) will be used to assess the patients' current level of cervical pain, and the worst and lowest level of pain experienced in the preceding week in the cervical area.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Active cervical range of motion</measure>
    <time_frame>Baseline,four weeks and Twelve weeks.</time_frame>
    <description>Measured by goniometer type crom</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pressure pain thresholds in cervical trigger points</measure>
    <time_frame>Baseline,four weeks and Twelve weeks.</time_frame>
    <description>Pressure pain thresholds (PPTs) will be measured with a pressure algometer (Baseline,</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The multidimensional health related quality of life.</measure>
    <time_frame>Baseline,four weeks and Twelve weeks.</time_frame>
    <description>Questionnaire SF 12.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neck Disability Index (NDI).</measure>
    <time_frame>Baseline,four weeks and Twelve weeks.</time_frame>
    <description>Questionnaire Neck Disability Index (NDI).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Pittsburgh Sleep Quality Index</measure>
    <time_frame>Baseline,four weeks and Twelve weeks.</time_frame>
    <description>The Pittsburgh Sleep Quality Index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The study of anxiety, depression and stress</measure>
    <time_frame>Baseline,four weeks and Twelve weeks.</time_frame>
    <description>Scale 21 (DASS-21)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Cervical Syndrome</condition>
  <arm_group>
    <arm_group_label>EXPERIMENTAL GROUP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The intervention for this group consisted of 10 sessions with Transcranial Direct Current Stimulation for a month.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CONTROL GROUP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The intervention for this group consisted of 10 sessions with Transcutaneous Electrical Nerve Stimulation (TENS) for a month.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Physiotherapy treatment with physium device.</intervention_name>
    <description>The intervention for this group consisted of 10 sessions with Transcranial Direct Current Stimulation for a month.</description>
    <arm_group_label>EXPERIMENTAL GROUP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Conventional physiotherapy treatment.</intervention_name>
    <description>The intervention for this group consisted of 10 sessions with Electrical Nerve Stimulation (TENS) for a month.</description>
    <arm_group_label>CONTROL GROUP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients of both sexes,&#xD;
&#xD;
          -  Aged between 18 and 60 years, in an&#xD;
&#xD;
          -  Active state of pain and diagnosed with a month of evolution.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - Patients who are pregnant, have pacemaker and those Surgically operated cervical spine -&#xD;
        Patients who have been treated with Transcranial Direct Current Stimulation a month&#xD;
        earlier.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>manuel Rodríguez Huguet, Physiotherapy</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Cádiz</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>manuel Rodríguez Huguet, Physiotherapy</last_name>
    <phone>606176814</phone>
    <email>manuel.rodriguez@uca.es</email>
  </overall_contact>
  <reference>
    <citation>Whiteford CM, Steinbeck L, Dommerholt J. On &quot;Clinical Practice Guideline for Physical Therapy Assessment and Treatment in Patients With Nonspecific Neck Pain,&quot; Bier JD, Scholten-Peeters WGM, Staal JB, et al. Phys Ther. 2018;98:162-171. Phys Ther. 2018 Sep 1;98(9):819-820. doi: 10.1093/ptj/pzy078.</citation>
    <PMID>29961845</PMID>
  </reference>
  <reference>
    <citation>Cohen SP. Epidemiology, diagnosis, and treatment of neck pain. Mayo Clin Proc. 2015 Feb;90(2):284-99. doi: 10.1016/j.mayocp.2014.09.008. Review.</citation>
    <PMID>25659245</PMID>
  </reference>
  <reference>
    <citation>Cohen SP, Hooten WM. Advances in the diagnosis and management of neck pain. BMJ. 2017 Aug 14;358:j3221. doi: 10.1136/bmj.j3221. Review.</citation>
    <PMID>28807894</PMID>
  </reference>
  <reference>
    <citation>Blanpied PR, Gross AR, Elliott JM, Devaney LL, Clewley D, Walton DM, Sparks C, Robertson EK. Neck Pain: Revision 2017. J Orthop Sports Phys Ther. 2017 Jul;47(7):A1-A83. doi: 10.2519/jospt.2017.0302.</citation>
    <PMID>28666405</PMID>
  </reference>
  <reference>
    <citation>Côté P, Yu H, Shearer HM, Randhawa K, Wong JJ, Mior S, Ameis A, Carroll LJ, Nordin M, Varatharajan S, Sutton D, Southerst D, Jacobs C, Stupar M, Taylor-Vaisey A, Gross DP, Brison RJ, Paulden M, Ammendolia C, Cassidy JD, Loisel P, Marshall S, Bohay RN, Stapleton J, Lacerte M. Non-pharmacological management of persistent headaches associated with neck pain: A clinical practice guideline from the Ontario protocol for traffic injury management (OPTIMa) collaboration. Eur J Pain. 2019 Jul;23(6):1051-1070. doi: 10.1002/ejp.1374. Epub 2019 Feb 28. Review.</citation>
    <PMID>30707486</PMID>
  </reference>
  <reference>
    <citation>Fitzgibbon BM, Schabrun SM. Transcranial Direct Current Stimulation for Pain Disorders: Challenges and New Frontiers. Clin Pharmacol Ther. 2019 Oct;106(4):717-719. doi: 10.1002/cpt.1544. Epub 2019 Jul 15.</citation>
    <PMID>31309544</PMID>
  </reference>
  <reference>
    <citation>Yalinay Dikmen P, Yavuz BG, Aydinlar EI. The relationships between migraine, depression, anxiety, stress, and sleep disturbances. Acta Neurol Belg. 2015 Jun;115(2):117-22. doi: 10.1007/s13760-014-0312-0. Epub 2014 Jun 3.</citation>
    <PMID>24889393</PMID>
  </reference>
  <reference>
    <citation>Schwartz DP, Robbins MS. Primary headache disorders and neuro-ophthalmologic manifestations. Eye Brain. 2012 Sep 13;4:49-61. doi: 10.2147/EB.S21841. eCollection 2012. Review.</citation>
    <PMID>28539781</PMID>
  </reference>
  <reference>
    <citation>Nitsche MA, Paulus W. Transcranial direct current stimulation--update 2011. Restor Neurol Neurosci. 2011;29(6):463-92. doi: 10.3233/RNN-2011-0618. Review.</citation>
    <PMID>22085959</PMID>
  </reference>
  <reference>
    <citation>Martelletti P, Jensen RH, Antal A, Arcioni R, Brighina F, de Tommaso M, Franzini A, Fontaine D, Heiland M, Jürgens TP, Leone M, Magis D, Paemeleire K, Palmisani S, Paulus W, May A; European Headache Federation. Neuromodulation of chronic headaches: position statement from the European Headache Federation. J Headache Pain. 2013 Oct 21;14:86. doi: 10.1186/1129-2377-14-86.</citation>
    <PMID>24144382</PMID>
  </reference>
  <reference>
    <citation>Charvet LE, Shaw MT, Bikson M, Woods AJ, Knotkova H. Supervised transcranial direct current stimulation (tDCS) at home: A guide for clinical research and practice. Brain Stimul. 2020 May - Jun;13(3):686-693. doi: 10.1016/j.brs.2020.02.011. Epub 2020 Feb 10.</citation>
    <PMID>32289698</PMID>
  </reference>
  <reference>
    <citation>Caulfield KA, Badran BW, DeVries WH, Summers PM, Kofmehl E, Li X, Borckardt JJ, Bikson M, George MS. Transcranial electrical stimulation motor threshold can estimate individualized tDCS dosage from reverse-calculation electric-field modeling. Brain Stimul. 2020 Jul - Aug;13(4):961-969. doi: 10.1016/j.brs.2020.04.007. Epub 2020 Apr 21.</citation>
    <PMID>32330607</PMID>
  </reference>
  <reference>
    <citation>DaSilva AF, Truong DQ, DosSantos MF, Toback RL, Datta A, Bikson M. State-of-art neuroanatomical target analysis of high-definition and conventional tDCS montages used for migraine and pain control. Front Neuroanat. 2015 Jul 15;9:89. doi: 10.3389/fnana.2015.00089. eCollection 2015.</citation>
    <PMID>26236199</PMID>
  </reference>
  <reference>
    <citation>Auvichayapat P, Janyacharoen T, Rotenberg A, Tiamkao S, Krisanaprakornkit T, Sinawat S, Punjaruk W, Thinkhamrop B, Auvichayapat N. Migraine prophylaxis by anodal transcranial direct current stimulation, a randomized, placebo-controlled trial. J Med Assoc Thai. 2012 Aug;95(8):1003-12.</citation>
    <PMID>23061303</PMID>
  </reference>
  <reference>
    <citation>Straudi S, Buja S, Baroni A, Pavarelli C, Pranovi G, Fregni F, Basaglia N. The effects of transcranial direct current stimulation (tDCS) combined with group exercise treatment in subjects with chronic low back pain: a pilot randomized control trial. Clin Rehabil. 2018 Oct;32(10):1348-1356. doi: 10.1177/0269215518777881. Epub 2018 May 21.</citation>
    <PMID>29783893</PMID>
  </reference>
  <reference>
    <citation>Andrade SM, de Brito Aranha REL, de Oliveira EA, de Mendonça CTPL, Martins WKN, Alves NT, Fernández-Calvo B. Transcranial direct current stimulation over the primary motor vs prefrontal cortex in refractory chronic migraine: A pilot randomized controlled trial. J Neurol Sci. 2017 Jul 15;378:225-232. doi: 10.1016/j.jns.2017.05.007. Epub 2017 May 3.</citation>
    <PMID>28566169</PMID>
  </reference>
  <reference>
    <citation>Przeklasa-Muszyńska A, Kocot-Kępska M, Dobrogowski J, Wiatr M, Mika J. Transcranial direct current stimulation (tDCS) and its influence on analgesics effectiveness in patients suffering from migraine headache. Pharmacol Rep. 2017 Aug;69(4):714-721. doi: 10.1016/j.pharep.2017.02.019. Epub 2017 Mar 1.</citation>
    <PMID>28551531</PMID>
  </reference>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>January 24, 2021</study_first_submitted>
  <study_first_submitted_qc>January 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 28, 2021</study_first_posted>
  <last_update_submitted>February 16, 2021</last_update_submitted>
  <last_update_submitted_qc>February 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Cadiz</investigator_affiliation>
    <investigator_full_name>Manuel Rodriguez Huguet</investigator_full_name>
    <investigator_title>Clinical professor</investigator_title>
  </responsible_party>
  <keyword>Neck Pain</keyword>
  <keyword>Physical Therapy Modalities</keyword>
  <keyword>Manual Therapy</keyword>
  <keyword>massage</keyword>
  <keyword>Transcranial Direct Current Stimulation</keyword>
  <keyword>Transcutaneous electrical nerve stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neck Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

